Co-med GmbH & Co.KG
Industry / private company
Location:
Hannover,
Germany (DE)
ISNI: -
Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry (2022)
Stoelzl D, Boraczynski N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al.
Conference contribution
Assessment of the Severity of Atopic Dermatitis by Physicians and Patients depending on Gender: Results from the German Atopic Dermatitis Registry TREATgermany (2021)
Heinrich L, Haufe E, Abraham S, Heratizadeh A, Harder , Kleinheinz A, Wollenberg A, et al.
Conference contribution
THE GERMAN AD REGISTRY TREATGERMANY: RESULTS FROM AN INTERIM DATA ANALYSIS ON BASELINE CHARACTERISTICS, COMORBIDITIES AND TREATMENT HISTORY (2021)
Heratizadeh A, Haufe E, Stoelzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, et al.
Conference contribution
Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany (2020)
Heratizadeh A, Haufe E, Stoelzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, et al.
Journal article
Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry (2019)
Apfelbacher CJ, Ofenloch RF, Weisshaar E, Molin S, Bauer A, Mahler V, Heinrich A, et al.
Journal article